/ /

Ophthalmology

Punctal plug drug delivery attractive method for managing glaucomaPunctal plug-based delivery systems for sustained delivery of glaucoma medications represent new and versatile technology that is under development. The hope is it can help with the problem of patient compliance when managing mild-moderate glaucoma, said Marlene Moster, MD.
Add-on injectable IOL for pseudophakic AMD maintains near visionResults from 1 year of follow-up in a multicenter clinical trial show that an add-on (Scharioth Macula Lens [SML], Medicontour) increases near vision without affecting distance vision in pseudophakic patients with age-related macular degeneration (AMD).
NLP status after open-globe injury not always permanentManagement of patients with loss of light perception after open-globe injury has historically been to observe or enucleate the eye with the goal of reducing the risk of sympathetic ophthalmia. Existing data, however, support rethinking that paradigm and instead considering surgery for carefully selected patients who have a chance for recovering vision.
The role of ophthalmologists in the opioid epidemicAn observational cohort study, published in JAMA Ophthalmology, used Medicare Part D data to assess the number of opioid prescriptions written by ophthalmologists in the United States.
Sustained drug-delivery technologies shape promising futureDevelopment of technologies for sustained drug delivery is a topic of great interest among retina specialists considering the number of chronic conditions that are managed with repeated intravitreal injections.
Corneal inlays play increasing role in presbyopiaAs the number of LASIK procedures being performed continues to fall worldwide, correction of presbyopia is receiving increasing attention as being the final frontier and “holy grail” for refractive surgery, said Wayne Crewe-Brown, MD, at Refractive Surgery 2017.
Schepens lecturer traces advent, evolution of ophthalmic trialsClinical trials are an indispensable ordeal that are the gold standard for assessing risks and benefits of treatments, said Frederick L. Ferris III, MD.
Gene therapy benefits for retinal dystrophies persist through trialResults from 3 years of follow-up in the phase III trial investigating treatment with adeno-associated viral vector delivery of human RPE65 (voretigene neparvovec, Spark Therapeutics) show this gene therapy has an acceptable safety profile.
Staying calm while navigating through LASIK complicationsEncountering complications is inevitable for anyone who performs LASIK, and when the complication occurs intraoperatively, surgeons are often faced with the need to make a decision quickly, said Priyanka Sood, MD.
RLE choice factors in benefits, risks, alternativesRemoval of the crystalline lens was developed as a procedure to treat the media opacity, but advances in surgical techniques and in pseudophakic IOL technology have increased the functional use of lens-based refractive surgery, said William F. Wiley, MD.